Status:
UNKNOWN
The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21
Lead Sponsor:
Meiji China Investment Co.,Ltd
Conditions:
H. Pylori Infection
Eligibility:
All Genders
4-6 years
Phase:
NA
Brief Summary
The goal of this randomized, open-label, interventional trial is to study the efficacy of treatment for Helicobacter Pylori Infection in Preschooler aged 4-6 by Meiji Yoghurt with LG21. The main quest...
Eligibility Criteria
Inclusion
- Preschooler aged 4-6 years
- H. pylori positive
- Drink milk or milk beverages regularly (more than three times a week) before joining the study
- ICF signed
- Parents or guardians agree not to participate in other interventional clinical studies during this study
Exclusion
- Has potential metabolic class or chronic disease
- Use of antibiotics within 7 days before randomization (as judged by the trial responsible physician)
- People who have been treated for eradication of Helicobacter pylori
- Pharmaceuticals, medicinal skin care products (medical external products) and health foods that may affect gastric symptoms have been commonly used since more than one month ago
- Already under digestive system treatment
- Has lactose intolerance or protein allergy
- Those whose families had plans to leave Jinhua City during the study period
- Fails to comply with the provisions of the protocol
- Those who are deemed unsuitable as subjects by the physician
Key Trial Info
Start Date :
September 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06045494
Start Date
September 26 2023
End Date
January 30 2024
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaitai Biotech Lab
Hangzhou, Zhejiang, China